Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Research Article

Prevalence and Outcomes of Infections in Critically-ill Paediatric Oncology Patients: A Retrospective Observation Study

Author(s): Karen K.Y. Leung, Pak Leung Ho, Sally C.Y. Wong, Wilson Y.K. Chan and Kam Lun Ellis Hon*

Volume 21, Issue 2, 2025

Published on: 24 January, 2024

Page: [174 - 185] Pages: 12

DOI: 10.2174/0115733963264717231208114248

Price: $65

Open Access Journals Promotions 2
Abstract

Purpose: The survival of paediatric oncology patients has improved substantially in the past decades due to advances in the field of oncology. Modern cancer treatments often come with life-threatening complications, of which infection is one of the most common causes in this patient population. This study aims to investigate the prevalence and outcomes of common infections in haemato-oncology patients during their stay in paediatric intensive care unit (PICU) and to identify any factors associated with these infections.

Methods: A retrospective observational study was conducted on all children with a haemato-oncology diagnosis or who underwent haematopoietic stem cell transplantation (HSCT) and who were admitted to the Hong Kong Children’s Hospital PICU over a one-year period. Infection characteristics and patient outcomes were evaluated and compared between different sub-groups. Univariable and multi-variable analyses were employed to identify risk factors associated with the development of active infection.

Results: Forty-five (36.3%) of 124 critically ill haemato-oncology admissions to PICU were associated with infections, of which 31 (25%) admissions involved bacterial infections, 26 (20.9%) involved viral infections and 6 (4.8%) involved fungal infections. Bloodstream infection was the most common type of infection. More than half (61.3%) of the bacterial infections were due to an antibiotic-resistant strain. After adjusting for confounding variables, post-HSCT status and neutropenia were significantly associated with active infections.

Conclusion: Infections in critically-ill haemato-oncological patients are associated with post haematopoietic stem cell transplant status and neutropenia. Further study is warranted to review effective strategies that may mitigate the likelihood of infection in this patient population.

Keywords: Critical care, critical illness, haematology, infection, intensive care, oncology, paediatrics, stem cell transplantation.

Graphical Abstract
[1]
Aljabari S, Balch A, Larsen GY, Fluchel M, Workman JK. Severe sepsis-associated morbidity and mortality among critically ill children with cancer. J Pediatr Inten Care 2019; 8(3): 122-9.
[http://dx.doi.org/10.1055/s-0038-1676658] [PMID: 31404226]
[2]
Jena S, Hasan S, Panigrahi R, Das P, Mishra N, Saeed S. Chemotherapy-associated oral complications in a south Indian population: A cross-sectional study. J Med Life 2022; 15(4): 470-8.
[http://dx.doi.org/10.25122/jml-2021-0342] [PMID: 35646189]
[3]
Bailey LC, Reilly AF, Rheingold SR. Infections in pediatric patients with hematologic malignancies. Semin Hematol 2009; 46(3): 313-24.
[http://dx.doi.org/10.1053/j.seminhematol.2009.03.010] [PMID: 19549582]
[4]
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer 2005; 103(7): 1457-67.
[http://dx.doi.org/10.1002/cncr.20910] [PMID: 15712273]
[5]
Straney L, Clements A, Parslow RC, et al. Paediatric index of mortality 3: An updated model for predicting mortality in pediatric intensive care. Pediatr Crit Care Med 2013; 14(7): 673-81.
[http://dx.doi.org/10.1097/PCC.0b013e31829760cf] [PMID: 23863821]
[7]
University of Leeds and Leicester. PICANet admission dataset definitions manual. 2020. Available from:https://www.picanet.org.uk/wp-content/uploads/sites/25/2020/11/PICANet-Web-Admission-Dataset-Manual-v5.4_-Nov-2020.pdf
[8]
National Health Service Digital. Organ system supported. 2021. Available from:https://www.datadictionary.nhs.uk/data_elements/organ_system_supported.html
[9]
Jones GAL, Ramnarayan P, Raman S, et al. Protocol for a randomised pilot multiple centre trial of conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU). BMJ Open 2017; 7(12): e019253.
[http://dx.doi.org/10.1136/bmjopen-2017-019253] [PMID: 29247112]
[10]
Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6(1): 2-8.
[http://dx.doi.org/10.1097/01.PCC.0000149131.72248.E6] [PMID: 15636651]
[11]
Meert KL, Banks R, Holubkov R, Pollack MM. Morbidity and mortality in critically Ill children. II. A qualitative patient-level analysis of pathophysiologies and potential therapeutic solutions. Crit Care Med 2020; 48(6): 799-807.
[http://dx.doi.org/10.1097/CCM.0000000000004332] [PMID: 32301845]
[12]
Pollack MM, Holubkov R, Funai T, et al. Pediatric intensive care outcomes: Development of new morbidities during pediatric critical care. Pediatr Crit Care Med 2014; 15(9): 821-7.
[http://dx.doi.org/10.1097/PCC.0000000000000250] [PMID: 25226501]
[13]
Pollack MM, Holubkov R, Glass P, et al. Functional status scale: New pediatric outcome measure. Pediatrics 2009; 124(1): e18-28.
[http://dx.doi.org/10.1542/peds.2008-1987] [PMID: 19564265]
[14]
Pollack MM, Banks R, Holubkov R, Meert KL. Long-term outcome of picu patients discharged with new, functional status morbidity. Pediatr Crit Care Med 2020; 22(1): 27-39.
[15]
Pollack MM, Banks R, Holubkov R, Meert KL. Morbidity and mortality in critically Ill children. I. Pathophysiologies and potential therapeutic solutions. Crit Care Med 2020; 48(6): 790-8.
[http://dx.doi.org/10.1097/CCM.0000000000004331] [PMID: 32301842]
[16]
Leung KKY, Ray S, Chan GCF, Hon KL. Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong. Int J Clin Oncol 2022; 27(12): 1904-15.
[http://dx.doi.org/10.1007/s10147-022-02244-3] [PMID: 36149516]
[17]
Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33(7): 1538-48.
[http://dx.doi.org/10.1097/01.CCM.0000168253.91200.83] [PMID: 16003060]
[18]
Dorofaeff T, Mohseni-Bod H, Cox PN. Infections in the PICU. Textbook of Clinical Pediatrics. Berlin, Heidelberg: Springer 2012; pp. 2537-63.
[http://dx.doi.org/10.1007/978-3-642-02202-9_268]
[19]
Peter Donnelly J, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 2020; 71(6): 1367-76.
[http://dx.doi.org/10.1093/cid/ciz1008] [PMID: 31802125]
[20]
Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302(21): 2323-9.
[http://dx.doi.org/10.1001/jama.2009.1754] [PMID: 19952319]
[21]
McArdle AJ, Turkova A, Cunnington AJ. When do co-infections matter? Curr Opin Infect Dis 2018; 31(3): 209-15.
[http://dx.doi.org/10.1097/QCO.0000000000000447] [PMID: 29698255]
[22]
Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr 2002; 140(4): 432-8.
[http://dx.doi.org/10.1067/mpd.2002.122499] [PMID: 12006957]
[23]
Ford-Jones EL, Mindorff CM, Langley JM, et al. Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr Infect Dis J 1989; 8(10): 668-75.
[http://dx.doi.org/10.1097/00006454-198910000-00002] [PMID: 2812911]
[24]
Raymond J, Aujard Y. Nosocomial infections in pediatric patients: A European, multicenter prospective study. Infect Control Hosp Epidemiol 2000; 21(4): 260-3.
[http://dx.doi.org/10.1086/501755] [PMID: 10782588]
[25]
de León-Rosales SP, Molinar-Ramos F, Domínguez-Cherit G, Rangel-Frausto SM, Vázquez-Ramos VG. Prevalence of infections in intensive care units in Mexico: A multicenter study. Crit Care Med 2000; 28(5): 1316-21.
[http://dx.doi.org/10.1097/00003246-200005000-00010] [PMID: 10834672]
[26]
Barsanti MC, Woeltje KF. Infection prevention in the intensive care unit. Infect Dis Clin North Am 2009; 23(3): 703-25.
[http://dx.doi.org/10.1016/j.idc.2009.04.012] [PMID: 19665091]
[27]
Alexander S, Nieder M, Zerr DM, Fisher BT, Dvorak CC, Sung L. Prevention of bacterial infection in pediatric oncology: What do we know, what can we learn? Pediatr Blood Cancer 2012; 59(1): 16-20.
[http://dx.doi.org/10.1002/pbc.23416] [PMID: 22102612]
[28]
University of Wisconsin Hospitals and Clinics Authority. Granulocyte colony stimulating factor - Adult/Pediatric - Inpatient/ambulatory clinical practice guideline. 2015. Available from: https:// www.uwhealth.org/cckm/cpg/medications/Granulocyte-Colony-Stimulating-Factor---Pediatric.Adult---Inpatient.Ambulatory-15.09.18---new-links.pdf
[29]
Clark OAC, Lyman GH, Castro AA, Clark LGO, Djulbegovic B. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: A meta-analysis of randomized controlled trials. J Clin Oncol 2005; 23(18): 4198-214.
[http://dx.doi.org/10.1200/JCO.2005.05.645] [PMID: 15961767]
[30]
Miller SE, Maragakis LL. Central line-associated bloodstream infection prevention. Curr Opin Infect Dis 2012; 25(4): 412-22.
[http://dx.doi.org/10.1097/QCO.0b013e328355e4da] [PMID: 22766647]
[31]
Renk H, Sarmisak E, Spott C, Kumpf M, Hofbeck M, Hölzl F. Antibiotic stewardship in the PICU: Impact of ward rounds led by paediatric infectious diseases specialists on antibiotic consumption. Sci Rep 2020; 10(1): 8826.
[http://dx.doi.org/10.1038/s41598-020-65671-0] [PMID: 32483370]
[32]
O’Connell NH, Humphreys H. Intensive care unit design and environmental factors in the acquisition of infection. J Hosp Infect 2000; 45(4): 255-62.
[http://dx.doi.org/10.1053/jhin.2000.0768] [PMID: 10981659]
[33]
Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 2005; 33(8): 1845-53.
[http://dx.doi.org/10.1097/01.CCM.0000171849.04952.79] [PMID: 16096464]
[34]
Rimawi RH, Mazer MA, Siraj DS, Gooch M, Cook PP. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med 2013; 41(9): 2099-107.
[http://dx.doi.org/10.1097/CCM.0b013e31828e9863] [PMID: 23873275]
[35]
Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 Update. J Clin Oncol 2017; 35(18): 2082-94.
[http://dx.doi.org/10.1200/JCO.2016.71.7017] [PMID: 28459614]
[36]
Wingard JR. Overview of infections following hematoietic cell transplantation. In: Post TW, Ed. UpToDate. Waltham, MA 2020.
[37]
Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med (Korean Assoc Intern Med) 2018; 33(2): 256-76.
[http://dx.doi.org/10.3904/kjim.2018.036] [PMID: 29506345]
[38]
Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplantation recipients. Mediterr J Hematol Infect Dis 2015; 7(1): e2015045.
[http://dx.doi.org/10.4084/mjhid.2015.045] [PMID: 26185610]
[39]
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant 2009; 15(10): 1143-238.
[http://dx.doi.org/10.1016/j.bbmt.2009.06.019] [PMID: 19747629]
[40]
Blot N, Schneider P, Young P, et al. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant. Bone Marrow Transplant 2000; 26(8): 903-5.
[http://dx.doi.org/10.1038/sj.bmt.1702591] [PMID: 11081393]
[41]
Blackstock JL, Parikh SH, Talbert JG. Herpes simplex virus in the pediatric bone marrow and stem cell transplantation patient. Biol Blood Marrow Transplant 2005; 11(2): 97-8.
[http://dx.doi.org/10.1016/j.bbmt.2004.12.288]
[42]
Committee on Infectious Diseases. Red Book 2018: Report of the Committee on Infectious Diseases. American Academy of Pediatrics 2018.
[43]
Emery V, Zuckerman M, Jackson G, et al. Management of cytomegalovirus infection in haemopoietic stem cell transplantation. Br J Haematol 2013; 162(1): 25-39.
[http://dx.doi.org/10.1111/bjh.12363] [PMID: 23647436]
[44]
Cho SY, Lee DG, Kim HJ. Cytomegalovirus infections after hematopoietic stem cell transplantation: Current status and future immunotherapy. Int J Mol Sci 2019; 20(11): 2666.
[http://dx.doi.org/10.3390/ijms20112666] [PMID: 31151230]
[45]
Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009; 113(23): 5711-9.
[http://dx.doi.org/10.1182/blood-2008-10-143560] [PMID: 19299333]
[46]
Styczynski J, van der Velden W, Fox CP, et al. Management of epstein-barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth european conference on infections in leukemia (ECIL-6) guidelines. Haematologica 2016; 101(7): 803-11.
[http://dx.doi.org/10.3324/haematol.2016.144428] [PMID: 27365460]
[47]
Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol 2013; 6(1): 94.
[http://dx.doi.org/10.1186/1756-8722-6-94] [PMID: 24341630]
[48]
Collaco JM, Gower WA, Mogayzel PJ Jr. Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: Overview, diagnostic considerations, and infectious complications. Pediatr Blood Cancer 2007; 49(2): 117-26.
[http://dx.doi.org/10.1002/pbc.21061] [PMID: 17029246]
[49]
Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005; 130(4): 595-603.
[http://dx.doi.org/10.1111/j.1365-2141.2005.05649.x] [PMID: 16098075]
[50]
Chakrabarti S, Collingham KE, Fegan CD, Pillay D, Milligan DW. Adenovirus infections following haematopoietic cell transplantation: Is there a role for adoptive immunotherapy? Bone Marrow Transplant 2000; 26(3): 305-7.
[http://dx.doi.org/10.1038/sj.bmt.1702508] [PMID: 10967570]
[51]
Tragiannidis A, Dokos C, Lehrnbecher T, Groll AH. Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: Review of the literature and options for clinical practice. Drugs 2012; 72(5): 685-704.
[http://dx.doi.org/10.2165/11599810-000000000-00000] [PMID: 22413762]
[52]
Alfaro GMM, Gans HA. Prevention of infections in the hematopoietic stem cell transplant recipient. Pediatric Transplant and Oncology Infectious Diseases. Philadelphia, PA: Elsevier 2021; pp. 46-53.
[53]
Maertens J, Cesaro S, Maschmeyer G, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 2016; 71(9): 2397-404.
[http://dx.doi.org/10.1093/jac/dkw157] [PMID: 27550992]
[54]
Burton C, Hanisch B. Pneumocystis pneumonia. Pediatric Transplant and Oncology Infectious Diseases. Philadelphia, PA: Elsevier 2020; pp. 241-246.e3.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy